Biolase Inc (BIOL)
0.1466
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
0.1466
0.00 (0.00%)
After-Hours: 20:00
Biolase Cash from Financing (Quarterly): 0.885M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.885M |
| September 30, 2023 | 3.756M |
| June 30, 2023 | 4.276M |
| March 31, 2023 | 8.517M |
| December 31, 2022 | -0.032M |
| September 30, 2022 | -0.214M |
| June 30, 2022 | 4.849M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.068M |
| September 30, 2021 | 0.075M |
| June 30, 2021 | -0.014M |
| March 31, 2021 | 29.82M |
| December 31, 2020 | -0.053M |
| September 30, 2020 | 15.39M |
| June 30, 2020 | 9.128M |
| March 31, 2020 | -0.117M |
| December 31, 2019 | 8.305M |
| September 30, 2019 | -0.05M |
| June 30, 2019 | 2.463M |
| March 31, 2019 | 0.003M |
| December 31, 2018 | 10.00M |
| September 30, 2018 | 1.50M |
| June 30, 2018 | -1.893M |
| March 31, 2018 | 1.624M |
| December 31, 2017 | 11.35M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.104M |
| June 30, 2017 | 10.42M |
| March 31, 2017 | -0.043M |
| December 31, 2016 | -0.049M |
| September 30, 2016 | 9.485M |
| June 30, 2016 | -0.043M |
| March 31, 2016 | -0.043M |
| December 31, 2015 | -0.083M |
| September 30, 2015 | -0.024M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.002M |
| December 31, 2014 | 34.82M |
| September 30, 2014 | 8.259M |
| June 30, 2014 | 0.399M |
| March 31, 2014 | 3.276M |
| December 31, 2013 | -0.315M |
| September 30, 2013 | 4.11M |
| June 30, 2013 | 3.352M |
| March 31, 2013 | 1.70M |
| December 31, 2012 | -0.552M |
| September 30, 2012 | 0.043M |
| June 30, 2012 | 1.791M |
| March 31, 2012 | 0.277M |
| December 31, 2011 | -0.246M |
| September 30, 2011 | 0.044M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.214M
Minimum
Sep 2022
29.82M
Maximum
Mar 2021
4.582M
Average
0.885M
Median
Dec 2023
Cash from Financing (Quarterly) Benchmarks
| Dentsply Sirona Inc | -128.00M |
| Milestone Scientific Inc | 2.567M |
| Wellness Center USA Inc | 0.275M |
| Envista Holdings Corp | 3.30M |
| Sonendo Inc | 0.001M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.283M |
| Cash from Investing (Quarterly) | -0.003M |
| Free Cash Flow | -15.40M |
| Free Cash Flow Per Share (Quarterly) | -0.7225 |
| Free Cash Flow to Equity (Quarterly) | -2.408M |
| Free Cash Flow to Firm (Quarterly) | -1.867M |
| Free Cash Flow Yield | -7.69K% |